• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
  • New
Theragnostics, An Issue of PET Clinics

Theragnostics, An Issue of PET Clinics

9780443129216
352.75 zł
299.84 zł Save 52.91 zł Tax included
Lowest price within 30 days before promotion: 299.84 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
  • Contains 12 relevant, practice-oriented topics including theragnostics trials; neuroendocrine tumors:: diagnostics; prostate-specific membrane antigen:: diagnostics; theragnostics:: post-therapy imaging; fibroblast-activation-protein inhibitors (FAPI) theragnostics; and more.
  • Provides in-depth clinical reviews on theragnostics, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Product Details
Elsevier
100939
9780443129216
9780443129216

Data sheet

Publication date
2024
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
178 x 254
Weight (g)
450
  • Alpha and Beta Radiation for Theragnostics
    Neuroendocrine Tumors: Diagnostics
    Alpha-emitter Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
    Prostate-specific Membrane Antigen: Diagnostics
    Prostate-specific Membrane Antigen: Interpretation Criteria, Standardized Reporting, and the Use of Machine Learning
    Prostate-specific Membrane Antigen: Alpha-labeled Radiopharmaceuticals
    Prostate Cancer Radioligand Therapy: Beta-labeled Radiopharmaceuticals
    Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management: Preclinical and Clinical Developments of the Past 5 Years
    Treatment Response Imaging in Prostate Cancer
    Hepatic Radioembolization: A Multistep Theragnostic Procedure
Comments (0)